PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Nuclear Medicine & Allied Sciences, Delhi, India. Electronic address: anant.inmas@gov.in.\', \'Institute of Nuclear Medicine & Allied Sciences, Delhi, India.\', \'CSIR-Centre for Cellular and Molecular Biology, Hyderabad 500007, India; Academy for Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0024-3205(22)00111-410.1016/j.lfs.2022.120411
?:hasPublicationType
?:journal
  • Life sciences
is ?:pmid of
?:pmid
?:pmid
  • 35181310
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.071
?:rankingScore_hIndex
  • 145
is ?:relation_isRelatedTo_publication of
?:title
  • Glycolytic inhibitor 2-deoxy-d-glucose attenuates SARS-CoV-2 multiplication in host cells and weakens the infective potential of progeny virions.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all